Theravance to recruit 120 trial sites for Phase III trial in neurogenic orthostatic hypotension

neurogenic orthostatic hypotension is a rare subtype of orthostatic hypotension caused by underlying neurologic disorders that affect a specific part of the autonomic nervous system.